1-3 of 3
Authors: Yoshihiro Oka
Sort by
Journal Article
10243-IMT-3 LONG-TERM OUTCOME OF A COCKTAIL WILMS' TUMOR 1 (WT1) VACCINATION USING TWO HLA CLASS I PEPTIDES AND ONE CLASS II PEPTIDE AGAINST RECURRENT MALIGNANT GLIOMAS Open Access
Naoki Kagawa and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_5, December 2023, Page v23, https://doi.org/10.1093/noajnl/vdad141.092
Published: 10 December 2023
Journal Article
Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies Open Access
Chisato Yokota and others
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab091, https://doi.org/10.1093/noajnl/vdab091
Published: 29 June 2021
Journal Article
IMT-07 CLINICAL TRIAL OF A COCKTAIL WILMS’ TUMOR 1 (WT1) VACCINATION USING TWO HLA CLASS I PEPTIDES AND ONE CLASS II PEPTIDE FOR RECURRENT MALIGNANT GLIOMAS Open Access
Naoki Kagawa and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Page ii18, https://doi.org/10.1093/noajnl/vdz039.080
Published: 16 December 2019
Advertisement
Advertisement